Brief: Genmab Says Orbis Controls 4.99% Of Genmab A/S Voting Rights As Of March 27
March 30 (Reuters) - Genmab A/S GMAB.CO: GENMAB - ORBIS CONTROLS 4.99% OF GENMAB A/S VOTING RIGHTS AS OF MARCH 27, 2026 Source text: ID:nGNE1MKVLC Further company coverage: GMAB.CO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos